GU Ventures

About GU Ventures

GU Ventures AB is the holding company and incubator affiliated with the University of Gothenburg, headquartered in Gothenburg, Sweden. The company was founded in 1995 and has been managed by the University of Gothenburg since 1998, operating as wholly owned by the Swedish state as a public-sector venture builder rather than a conventional fund vehicle. The platform combines three functions in a single entity: a pre-seed and seed investor, a full-service incubator providing administrative and business-development support to research-spinoff founders, and a project accelerator that converts academic research into formed companies. Cumulative aggregate assets under management are not publicly disclosed in fund-style format because the entity is balance-sheet-funded by Swedish state appropriation, with annual portfolio turnover reported in the region of SEK 320 million. Since inception, GU Ventures has financed and initiated more than 240 companies and projects, generated approximately 30 exits and 11 IPOs, and maintains an active portfolio of around 55 companies as of 2024.

Investment thesis

GU Ventures invests at idea-to-pre-seed stage in research-based spinouts originating from the University of Gothenburg ecosystem, with selective extension to founders building outside the university so long as the venture is anchored in a unique sustainable product or service with scalable growth potential. Sector focus is concentrated in life sciences spanning therapeutics, diagnostics and medtech, and in technology spanning deeptech, software, materials and sustainable industrial technology, with an emerging thesis around textiles and circular-economy applications. Geographic focus is Sweden, with portfolio companies typically domiciled in Gothenburg or wider Västra Götaland. Approximately 87 percent of the active portfolio is mapped to one or more United Nations Sustainable Development Goals, embedding an implicit impact lens across the book. Ticket sizes are typically modest at sub-SEK 5 million per round, and capital is paired with non-dilutive incubator services including business development, financial administration, legal templating and lab-bench access.

Recent activity

Active portfolio companies include Cereno Scientific in life sciences and cardiovascular therapeutics (Nasdaq First North-listed), Toleranzia in life sciences and immunology, Surgical Science in life sciences and medtech (previously incubated and now Nasdaq Stockholm-listed), Mimbly in sustainable technology and water, and Hydroc Energy Storage in deeptech and energy. Recent realisations include Mycorena in food and alternative protein (2024) and prior IPO exits including Cellink in life sciences and bioprinting (IPO 2016) and Surgical Science in life sciences and medtech (IPO 2017). The platform continues to support University of Gothenburg-originated spinouts across life sciences and deeptech. Detailed buyer names and multiple data available on Pro at €49/month.